Navigation Links
Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
Date:5/11/2009

BRIDGEWATER, N.J., May 11 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that it has acquired from biotechnology company Antisoma plc the U.S. commercial rights to Oforta(TM) (fludarabine phosphate film-coated tablets), an oral B-cell chronic lymphocytic leukemia (CLL) drug. Oforta is currently approved in the United States for use as a second-line therapy to treat adults with B-cell CLL.

"We are extremely pleased to add Oforta to our existing oncology portfolio, and believe it represents an exciting opportunity for sanofi-aventis U.S.," said John Harrington, Vice President and Head of the Oncology Business Unit at sanofi-aventis U.S. "Sanofi-aventis is a company committed to identifying and exploring new treatment options for patients facing serious diseases, such as CLL. This agreement further supports our efforts to help patients and complements our strong heritage of providing therapies to treat cancer."

Antisoma currently licenses certain rights and purchases Oforta from Bayer Schering Pharma AG. As part of this transaction, sanofi-aventis U.S. will acquire these agreements.

Oforta is a nucleoside analogue designed to prevent cancer cells from dividing by inhibiting DNA synthesis. Oforta was granted accelerated review and later received approval from the U.S. Food and Drug Administration (FDA) in December 2008 to treat adult patients with B-cell CLL whose disease has not responded to, or has progressed during or after treatment with at least one standard alkylating-agent containing regimen. Oforta is an orally administered tablet formulation of fludarabine phosphate.

About Oforta

Oforta is indicated as a single agent for the treatment of adult patients with B-cell CLL whose disease has not responded to, or has progressed during or after treatment with at least one standard alkylating-agent containing regimen. Studies demonstrating clinical b
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
2. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
3. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
6. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
8. Cord Blood America to Acquire or Build Its Own Stem Cell Laboratory
9. ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center
10. Sigma-Aldrich Acquires Sigal Ltda and Expands Operations in Chile
11. Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... 2014 Advancing the front lines ... chemical and biological threats is the mission of ... Institute (WPI) and the Georgian National Academy of ... Peace and Security Programme of the North Atlantic ... Research Workshop series, the event is titled “Nanotechnology ...
(Date:9/12/2014)... On Thursday, September 11, 2014, the NASDAQ Composite ended ... the day 0.12% lower at 17,049.00, and the S&P 500 ... as seven out of ten sectors ended the session in ... day at 741.83, down 0.33%, while the index has advanced ... on the following equities: Exelixis Inc. (NASDAQ: EXEL ...
(Date:9/11/2014)... researchers have gained new insight into what may ... neuronal signaling associated with this disease. They did ... of healthy individuals and of patients with schizophrenia ... to release neurotransmitters, such as dopamine, that are ... various disorders. By discovering a simple method for ...
(Date:9/11/2014)... surface of graphene, a one atom thick sheet of ... graphene oxide; a form of graphene that could have ... industries. Applied as paint, it could provide an ultra-strong, ... , Graphene oxide solutions can be used to ... even conventional bricks. After a simple chemical treatment, the ...
Breaking Biology Technology:Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5Stem cells help researchers understand how schizophrenic brains function 2Graphene paints a corrosion-free future 2
... Israel, June 17 BSP Ltd.,( http://www.bsp.co.il/pressall.asp ) ... non-invasive diagnosis and monitoring of Ischemic Heart,Disease, announced ... private,funding round, that included existing shareholders in the ... the HyperQ(TM), a cutting-edge technology that offers,highly reliable, ...
... a trend of unprecedented,growth in biotechnology innovation, targeted ... in the past year in,terms of development and ... at the 2008 BIO International Convention in San ... the need to measure,innovation in the market, in ...
... 17 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ) ... in,a Phase 1 trial of PX-866 in patients ... compound designed to inhibit the activity of,phosphatidylinositol-3-kinase (PI-3K), ... a potent inhibitor of PI-3K, a component of ...
Cached Biology Technology:BSP Raises $2.6 Million Dollars From Private Investors 2In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 2In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 3In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 4In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 5Oncothyreon initiates Phase 1 trial of PX-866 cancer compound 2Oncothyreon initiates Phase 1 trial of PX-866 cancer compound 3Oncothyreon initiates Phase 1 trial of PX-866 cancer compound 4
(Date:9/12/2014)... happened on the way to dealing with climate ... dollars, worth of previously unreachable oil and natural ... and benefits from "fracking," which requires ... deep into underground rock formations, are the subject ... and government databases. The survey covers not only ...
(Date:9/11/2014)... autism often show a reduced frequency of social ... repetitive solitary behaviors. Autism has also been linked ... involved in processing emotions. Now Caltech researchers have ... that control whether the animal engages in social ... have implications for understanding neural circuit dysfunctions that ...
(Date:9/11/2014)... associate professor of mechanical engineering at Worcester ... the university,s Integrative Materials Design Center (iMdc), ... the National Science Foundation (NSF) to support ... manufacture metal-ceramic composites, which can be used ... efficient, while significantly increasing their performance. , ...
Breaking Biology News(10 mins):Stanford-led study assesses the environmental costs and benefits of fracking 2Stanford-led study assesses the environmental costs and benefits of fracking 3Stanford-led study assesses the environmental costs and benefits of fracking 4Tipping the balance of behavior 2Tipping the balance of behavior 3NSF funds new method for making materials that can make lighter, more efficient vehicles 2NSF funds new method for making materials that can make lighter, more efficient vehicles 3
... lab tests of "killer paper," a material intended for ... preserve foods by fighting the bacteria that cause spoilage. ... contains a coating of silver nanoparticles, which are powerful ... that silver already finds wide use as a bacteria ...
... contain atomic clues as to the habitats in which ... has important implications for predicting the effects of climate ... the animal kingdom. Applying a method previously only ... on plants, scientists from the University of Cambridge can ...
... MOUNTAIN VIEW, Calif., Jan. 10, 2011 Based ... monitoring market, Frost & Sullivan recognizes Cardiocom with ... for Enabling Technology. Cardiocom provides integrated clinical telehealth ... healthcare community. (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) ...
Cached Biology News:Insects hold atomic clues about the type of habitats in which they live 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 3Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 4
Fingerprinting II dimensioning techniques is an optional module that adds principal component analysis, multidimensional scaling, discriminant analysis and MANOVA, and self-organizing maps to the Fin...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
... Dyad instrument is the most advanced thermal ... world-class thermal performance, the Dyad also boasts ... as point-and-click navigation via touch pad or ... easily and economically expanded to a four-bay ...
...
Biology Products: